Form 4 Filing for CYTOKINETICS INC

This filing details a Form 4 submission for CYTOKINETICS INC (CYTK) on May 27, 2026. B. Lynne Parshall, a director, acquired 2,851 shares of Common Stock and was granted a Non-Qualified Stock Option to buy 4,301 shares of Common Stock. The stock option has an exercise price of $77.15, with an exercise date of June 27, 2026, and an expiration date of May 26, 2036. Both transactions are marked as direct ownership. Following these transactions, Ms. Parshall directly owns 20,784 shares of Common Stock and holds 4,301 stock options.